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doi:10.1016/j.ejvs.2008.04.005Abstract Background: Remote endarterectomy is a minimally invasive procedure which
combines open and endovascular surgery for the treatment of long segment superficial femoral
artery (SFA) occlusive disease. We conducted a systematic review of the medical literature to
analyze the indications, technical limitations and the outcome of remote SFA endarterectomy
(RSFAE).
Methods: The English literature was searched using the MEDLINE electronic database up to
February 2008. We considered studies comprising at least 10 patients treated with RSFAE
and reporting on the primary and/or secondary patency rates. Average primary and secondary
patency rates were obtained by weighting the data of each study by the number of limbs
treated.
Results: Our search identified 19 retrospective or prospective case series; no randomized con-
trolled trials comparing RSFAE with another treatment modality were identified. The average
technical success rate was 94% and the procedure-related complication rate was 14.7%. The
weighted mean cumulative primary patency rates were 60%, 57% and 35% at 1, 2 and 5 years,
respectively. The weighted mean assisted primary patency rates were 75%, 77% and 50% at 1, 2
and 5 years, respectively. The weighted mean secondary patency rates were 88% and 62% at 1
and 2 years, respectively.
Conclusions: RSFAE has acceptable short-, medium- and long-term results but patients should
undergo intensive surveillance postoperatively. Randomized controlled trials are needed to
assess the durability of this procedure as compared to conventional open bypass surgery.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.ukas, MSc, MD, PhD, Department of Vascular Surgery, University Hospital of Larissa, 411 10 Larissa,
30 2410 670042.
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Historically, femoro-popliteal bypass has been considered
the gold standard for the treatment of long segmental SFA
occlusive disease and the ideal graft is autologous saphe-
nous vein, whereas percutaneous transluminal angioplasty
and/or stenting has been suggested by the Transantlantic
Inter-Society Consensus (TASC) for the treatment of short
TASC type A lesions.1,2
Endarterectomy of the SFA is an old minimally invasive
‘‘endovascular’’ technique that was first described by Dos
Santos3 in the middle of the previous century. Instead of
the direct open approach for arterial endarterectomy, the
author proposed a semi-closed approach using a proximal
and distal arteriotomy and a ring stripper for the removal
of the atheroma from the femoro-popliteal segment. De-
spite the initial enthusiasm and the theoretical advantages
of the procedure, its use gradually reduced, as large trials
showed inferior results compared with vein bypass grafting.
In the modern era of endovascular approaches, Ho
et al.4 instigated new interest in SFA endarterectomy
with the evolution of the ‘‘remote’’ technique. This is
a minimally invasive procedure for the treatment of long
segment SFA occlusion, which combines open and endovas-
cular surgery (Fig. 1).5 Through a single groin incision and
an arteriotomy in the proximal SFA, the atherosclerotic
core is dissected out of the arterial adventitia using a ringFigure 1 (a) The atherosclerotic core is dissected out of the arte
the distal intimal core (arrow). (c) The whole intimal-atherosclero
cover the distal intimal flap (arrow).stripper and a ring strip cutter is then used to transect
the distal intimal core. Endoluminal stenting of the distal
intimal flap prevents any further dissection and provides
a smooth transition area.
The purpose of this article was to systematically review
the literature and analyze the indications, technical details
and the outcome of RSFAE based on evidence derived from
relevant studies.
Methods
Search strategy. A public domain database (MEDLINE) was
searched using a Web-based search engine (PubMed) for
articles published between August 1995, when the tech-
nique of remote endarterectomy was first described, and
February 2008. The literature search was confined to stud-
ies published in English. The keywords used were ‘‘remote
endarterectomy’’ and ‘‘superficial femoral artery AND
endarterectomy’’. A second-level search included manual
search of the reference lists of relevant articles. The liter-
ature search, study selection, and data extraction from the
relevant studies were performed by two independent
authors (GAA, SAA).
Study selection. Studies were considered for inclusion
based on the following criteria: 1. They included at least
10 patients with SFA occlusive disease treated with RSFAE,
2. They reported the primary and/or secondary patencyrial wall with a ring stripper. (b) The ring strip cutter transects
tic column has been removed. (d) A stent has been placed to
Table 1 Characteristics of studies
Authors Year Study type Patients Legs
Ali et al.6 2007 Retro/Single 18 18
Rosenthal et al.7 2006 Retro/Multi 210 210
Heerinckx et al.8 2006 Prosp/Single 92 102
Martin et al.9 2006 Prosp/Single 105 105
Devalia et al.10 2006 e/Single 30 33
Knight et al.11 2005 Prosp/Multi 61 62
Rosenthal et al.13 2004 Retro/Multi 60 60
Smeets et al.14 2003 Retro/Single 164 183
Rosenthal et al.15 2003 Retro/Single 21 21
Heijmen et al.16 2001 e/Single 41 41
Nelson et al.17 2001 Prosp/Single 17 17
Galland et al.18 2000 e/Single 30 32
Ho et al.19 2000 Prosp/Single 13 14
Ho and Moll20 1998 e/Single 90 103
Total 952 1001
312 G.A. Antoniou et al.rates. The process of identifying eligible clinical studies is
summarized in Fig. 2. Our search initially located 195
abstracts, and a full-text online library tool was used to
retrieve 28 relevant articles. Nineteen of these articles
fulfilled the above inclusion criteria.
Data abstraction and statistical analysis. Data ab-
stracted (where available) from individual studies were:
type of study (single or multi-centre, retrospective or pro-
spective), number of patients/legs treated, demographic
characteristics of the study population, Rutherford classifi-
cation for lower extremity ischaemia, nature of SFA lesion,
number of run-off vessels, technical success rate, reasons
for technical failure, procedure-related complications,
type of stent used, SFA endovascular grafting, mean in-
hospital stay, postoperative anticoagulation, mean ABPI in-
crease, patency rates, number of secondary interventions
to maintain patency, secondary bypass surgery rate and
amputation rate. The mean technical success rate and
mean cumulative primary, assisted primary and secondary
patency rates were averaged, weighting the data of each
study by the number of limbs treated. These patency values
were calculated for 12, 24 and 60 months following the pro-
cedure. Values were presented for a specific time-period
only if there were at least two studies to report for this
time-period.
Results
Nineteen relevant studies were identified using the afore-
mentioned criteria.6e24 There were three duplicate publi-
cations from the same centre.12,13,20e24 Only the most
recent report from these studies was considered for
further analysis.12,13,20,21 Additionally, two single-centre
studies from the same author team where thought to
contain duplicate cases20,21; the most recent report,
containing the larger number of patients, was included in
the final analysis.20 Furthermore, careful scrutiny of the
studies concluded that two multi-centre studies were
highly possible to contain overlapping data,7,12 so the larg-
est only of these series was taken into account in the final
data analysis,7 which included 14 clinical studies (Fig. 2).
All of these studies were retrospective or prospective
case series, single- or multicentre, as shown in Table 1.
No randomized controlled trials were found comparingAbstracts located initially: 195 
Articles retrieved and read: 28
Articles fulfilling the inclusion criteria: 19
Duplicate publications: 3
Publications excluded due to duplicate cases: 2
Articles included in the final analysis: 14 
Figure 2 Search strategy.RSFAE with another treatment modality for SFA occlusive
disease. Four multi-centre studies have been conduc-
ted,7,11e13 the greatest of which included 210 patients.7
Indications
The total number of patients and legs selected for RSFAE is
952 and 1001, respectively. The patients’ demographic
characteristics are shown in Table 2 and the clinical and
anatomical inclusion criteria for RSFAE are presented in
Table 3. It is evident from this table that there is wide vari-
ability in the Rutherford caregory. In particular, Rosenthal
et al.15 included patients treated for limb salvage only
and RSFAE was combined with distal vein bypass. There is
also considerable heterogeneity in the anatomical inclusion
criteria for RSFAE. In some studies the nature of the lesion
(occlusion/stenosis) as well as the length of occlusion is
clearly stated, whereas in some others the anatomical
criteria are ill-defined or not defined at all (Table 3). Simi-
larly, some studies comment on the status of the run off
vessels while others do not (Table 3). Almost all studies
though converge on the fact that the anatomical criteria
for RSFAE are multiple stenoses or lengthy occlusion of
the SFA with supragenicular reconstitution of the popliteal
artery and at least one patent crural vessel.
Technical details
The technical success rate for each individual study is
shown in Table 4. The technical success rate ranges from 65
to 100% and the mean technical success rate was 94%. All
patients with failed RSFAE underwent successful femoro-
popliteal bypass. Table 5 summarizes the reasons for tech-
nical failure sorted by frequency. The most common reason
for procedural failure is SFA perforation, encountered in
2.1% of the reported RSFAE attempts, followed by SFA cal-
cification (1.3%) and failure to pass the guide wire across
the popliteal plaque end-point (0.5%).
Additionally, Table 5 summarizes the procedure-related
complications sorted by frequency. The procedure-related
Table 2 Patient demographics
Author Male % Age Smoking % HTN % DM % CAD % Hyperlipidaemia %
Ali et al.6 50 62 (mean) NR NR NR NR NR
Rosenthal et al.7 59 62 (mean) 44 41 43 37 NR
Heerinckx et al.8 77 71 (mean) 63 51 26 NR 20
Martin et al.9 a 68 68 (mean) 35 41 31 NR 34
Devalia et al.10 73 64 (mean) NR NR 27 23 NR
Knight et al.11 67 69 (median) 84 NR 28 NR NR
Rosenthal et al.13 77 66 (mean) 47 48 43 35 NR
Smeets et al.14 64 63 (mean) 70 19 27 26 27
Rosenthal et al.15 67 69 (mean) 43 48 38 80 NR
Heijmen et al.16 80 70 (mean) 46 41 24 NR 34
Nelson et al.17 76 64 (mean) 65 53 59 65 41
Galland et al.18 73 64 (median) 40 50 27 23 10
Ho et al.19 77 68 (mean) 77 62 39 54 46
Ho and Moll20 69 68 (median) NR NR NR NR NR
HTN, Hypertension; DM, diabetes melitus; CAD, coronary artery disease; NR, not reported.
a including retrograde iliac endartrectomy (RIE) in 7 patients and combined RIE and RSFAE in 5 patients.
Remote Superficial Femoral Artery Endarterectomy 313complication rate was 14.7%. The most common procedure-
related complication was thrombus or fractured plaque
within the SFA, which was usually successfully removed
with an embolectomy catheter. There was also a 5.4% risk
of SFA perforation or rupture, demonstrated as extravasa-
tion of contrast at completion arteriography, which in the
majority of cases was self-limiting requiring no interven-
tion, whereas in a few cases graft or stent placement was
required. Popliteal access was required in 1.2% of success-
ful RSFAEs, most commonly in cases in which there was dif-
ficulty in crossing the guide wire from the distal
endarterectomy end-point.
Table 6 presents the type of stent and/or endograft used
for fixation of the distal endarterectomy end-point and
prevention of restenosis.Table 3 Criteria for RSFAE
Author RC 3(%) RC 4-5(%) Nature of SFA
Ali et al.6 22 78 TASC D
Rosenthal et al.7 75 25 TASC D
Heerinckx et al.8 74 26 occlusion of
Martin et al.9 57 43 occlusion of
Devalia et al.10 82 18 NR
Knight et al.11 90 10 mean length
Rosenthal et al.13 87 13 NR
Smeets et al.14 70 30 lengthy occlu
Rosenthal et al.15 a 0 100 NR
Heijmen et al.16 37 63 lengthy occlu
Nelson et al.17 47 53 lengthy occlu
Galland et al.18 80 25 53% occlusion
stenosis
Ho et al.19 43 57 median lengt
Ho and Moll20 70 30 95% lengthy o
RC, Rutherford classification; v, run off vessel; p, patient; v:p, numbe
NR, not reported.
a RSFAE combined with distal vein bypass.Table 7 shows the mean in-hospital stay ranging from 1.3
to 3.1 days. Only one study reported a mean in-hospital stay
of 7 days.16 Use of postoperative antithrombotic or antico-
agulation therapy varied considerably between the studies,
while some studies did not report on this treatment at all
(Table 7).
Outcome
The immediate outcome was demonstrated by the mean
ABPI increase (Table 8), which ranged from 0.26 to 0.52.
Postoperatively, all patients underwent a surveillance pro-
gram which included clinical examination, ABPI measure-
ment and duplex scanning carried out at 3-monthly
intervals. The short, medium and long term results oflesion Run off vessels
NR
NR
at least 10 cm at least 1 patent
crural artery
at least 10 cm NR
NR
of occlusion 25, 1 cm 1v:10p, 2v:25p, 3v:27p
NR
sion or multiple stenoses 1v:40p, 2v or 3v:143p
NR
sion 1v:8p, 2v:13p, 3v:20p
sion at least 1 patent
crural artery (mean 2, 2)
/41% occlusionþ stenosis/6% 1v:4p, 2v:10p, 3v:18p
h of occlusion 18 cm at least 1 patent
crural artery
cclusion/5% multiple stenoses NR
r of patients having the specific number of patent run off vessels;
Table 4 Technical success rate
Authors Technical success
rate (%)
Successful
RSFAEs
Ali et al.6 100 18
Rosenthal et al.7 100 210
Heerinckx et al.8 98 100
Martin et al.9 85 105
Devalia et al.10 79 26
Knight et al.11 NR 62
Rosenthal et al.13 NR 60
Smeets et al.14 94 172
Rosenthal et al.15 NR 21
Heijmen et al16 100 41
Nelson et al.17 65 11
Galland et al.18 78 25
Ho et al.19 100 14
Ho and Moll20 99 102
Total 967
Mean 91
Weighted mean 94
NR, not reported.
Table 6 Type of stent/SFA endograft
Authors Distal SFA stent
placement
Endarterectomized
SFA endograft
placement
Ali et al.6 Yes (self-expanding
Nitinol stent)
Yes (Viabahn or
Fluency)
Rosenthal et al.7 Yes (aSpire) No
Heerinckx et al.8 No Yes (Enduring)
Martin et al.9 Yes (NR) No
Devalia et al.10 Yes (Palmaz) No
Knight et al.11 Yes (aSpire) No
Rosenthal et al13 Yes (NR) No
Smeets et al.14 Yes (Palmaz) No
Rosenthal et al.15 Yes (NR) No
Heijmen et al.16 No Yes (Enduring)
Nelson et al.17 Yes (Palmaz or
Symphony)
No
Galland et al.18 Yes (Palmaz) No
Ho et al.19 Yes (Palmaz) Yes (Impra)
Ho and Moll20 Yes (Palmaz) No
NR, not reported.
314 G.A. Antoniou et al.various studies are represented by the patency rates (Table
8). The weighted mean cumulative primary patency rates at
1, 2 and 5 years were 60%, 57% and 35%, respectively. The
weighted mean assisted primary patency rates were 75%,
77% and 50% at 1, 2 and 5 years, respectively. The weighted
mean secondary patency rates were 88% and 62% at 1 and 2
years, respectively (Table 9). Only two studies10,14 reported
on the long term (60 months) results of RSFAE reporting
mean weighted cumulative and assisted primary patency
rates of 35% and 50%, respectively.
A number of interventions were performed to maintain
patency, including percutaneous transluminal balloon and
stent angioplasty, thrombectomy, thrombolysis and surgical
revision of the proximal and distal SFA, with a rate whichTable 5 Reasons of failure and complications
Reasons of technical failure Ratio (%) Failure
rate (%)
Pro
com
SFA perforation 34 2.1 SFA
pla
SFA calcification 22 1.3 SFA
Distal end-point could not
be crossed
8 0.5 Pop
Previous procedures on SFA 8 0.5 Fal
SFA avulsion 4 0.2 Bro
Inability to retrieve the ring 2 0.1 Gra
End
SFA perforation or SFA
calcification
22 1.3 Sub
of t
Total 100 6ranged from 9.1 to 63.4% (Table 10, Fig. 3). The indications
for intervention to maintain patency varied among the
studies depending on recurrent clinical symptoms and hae-
modynamic and duplex scanning parameters.
The percentage of patients who eventually required
femoro-popliteal bypass after failure of RSFAE ranged from
4.8 to 36.4% and the amputation rate varied from 0 to 28.6%
(Table 10).Discussion
Although RSFAE appears to be an appealing concept for the
treatment of long SFA lesions, this method has not yet been
validated as a treatment option. There are no randomized
controlled trials comparing RSFAE with another treatment
modality for SFA occlusive disease, such as subintimalcedure- related
plications
Ratio (%) Complication
rate (%)
thrombus/fractured
que-distal embolisation
48 7.2
rupture/perforation 36 5.4
liteal access 8 1.2
se aneurysm 4 0.5
ken ring 1 0.1
ft infection 1 0.1
ograft migration 1 0.1
intimal positioning
he guidewire/stent
1 0.1
100 14.7
Table 7 Mean hospital stay, postoperative
anticoagulation
Author Mean hosp.
stay (days)
Postop. treatment
Ali et al.6 2.3 NR
Rosenthal et al.7 1.3 Plavix or Aspirin
Heerinckx et al.8 NR Aspirin or ticlopidine
and buflomedil for at
least 1 year
Martin et al.9 2.52 Aspirin and Plavix
for at least 3 months
Devalia et al.10 NR NR
Knight et al.11 NR NR
Rosenthal et al.13 1.4 NR
Smeets et al.14 Aspirin, Persantin
or Plavix
Rosenthal et al.15 3.1 NR
Heijmen et al.16 7 Oral antocoagulant
for at least 6 months
Nelson et al.17 NR Aspirin
Galland et al.18 NR NR
Ho et al.19 NR Oral anticoagulant
for 6 months
Ho and Moll20 NR NR
NR, not reported.
Table 9 Weighted mean patency rates
Treatment
time (months)
12 24 60
Number of
papers
(references)
7 (6,8,10,11,17e19) 4 (10,18e20) 2 (10,14)
Number of
limbs
256 167 198
CPP 60 57 35
Number of
papers
(references)
7 (6,8,10,11,17,18) 3 (10,18,20) 2 (10,14)
Number of
limbs
242 153 198
APP 75 77 50
Number of
papers
(references)
6 (6,8,11,18,19) 2 (18,19)
Number of
limbs
219 39
SP 88 62
CPP, cumulative primary patency; APP, assisted primary
patency; SP, secondary patency.
Remote Superficial Femoral Artery Endarterectomy 315angioplasty or femoropopliteal bypass. Our review of the
literature on this occasion was focused in the assessment of
the feasibility and outcomes of remote endarterectomy.
The search of the pertinent literature has detected retro-
spective or prospective case series only, among which there
was great variability in several aspects, including demo-
graphic characteristics of the study population, clinical and
angiographic inclusion criteria for this treatment, and the
reporting of outcomes. Pooled analysis of the existing
literature was not possible because of these limitations.Table 8 Mean ABPI increase and patency rates
Author Mean ABPI
increase
% Cumulative
primary patency
Ali et al.6 0.51 42 (12 m)
Rosenthal et al.7 0.37 61 (33 m)
Heerinckx et al.8 NR 68 (12 m)/50 (36 m)
Martin et al.9 0.26 70 (30 m)
Devalia et al.10 NR 38 (12 m)/31 (24 m)/16 (60 m
Knight et al.11 NR 84 (6 m)/65 (12 m)/60 (18 m)
Rosenthal et al.13 0.36 61 (12,9 m) (mean)
Smeets et al.14 0.36 38 (60 m)
Rosenthal et al.15 0.52 71 (12.4 m)
Heijmen et al.16 0.34 42 (18 m)
Nelson et al.17 0.31 40 (12 m)
Galland et al.18 NR 40 (12 m)/29 (24 m)
Ho et al.19 0.37 70 (12 m)/61 (24 m)
Ho and Moll20 NR 71 (24 m)
m, months; NR, not reported.Therefore, the outcomes of RSFAE presented herein should
be approached with caution.
Our analysis of the relevant articles has shown that the
procedure was associated with a 6% failure rate and
a procedural complication rate of 14.7%. The most common
reasons for technical failure were SFA calcification and SFA
perforation accounting for 78% of the technical failures.
This percentage might be even higher if Martin et al.9 and
Smeets et al.14 had not largely excluded patients with ex-
tensive SFA calcification or renal failure from their studies.% Assisted
primary patency
% Secondary patency
70 (12 m) 70 (12 m)
70 (33 m) NR
73 (12 m)/60 (36 m) 98 (12 m)/89 (36 m)
76 (30 m) 80 (30 m)
) 77 (12 m)/65 (24 m)/60 (60 m) NR
95 (6 m)/82 (12 m)/70 (18 m) 98 (6 m)/83
(12 m)/72 (18 m)
83 (12.9 m) NR
48 (60 m) 49 (60 m)
81 (12.4 m) NR
NR 56 (18 m)
59 (12 m) NR
72 (12 m)/57 (24 m) 76 (12 m)/57 (24 m)
NR 78 (12 m)/70 (24 m)
86 (24 m) NR
Table 10 Rate of secondary interventions, bypass rate and amputation rate
Author Rate of secondary
interventions
Secondary
bypass rate
Amputation rate Duration of follow-up
in months
Ali et al.6 33.3 11.11 11.11 16 (mean)
Rosenthal et al.7 23.8 14.76 5.24 NR
Heerinckx et al.8 53 8 0 36 (mean)
Martin et al.9 12.4 12.38 6.67 19 (mean)
Devalia et al.10 NR 11.54 7.69 3e84
Knight et al.11 25.8 20.97 0 16.5 (median)
Rosenthal et al.13 23.3 NR 1.67 NR
Smeets et al.14 27.3 NR 2.91 29.3 (median)
Rosenthal et al.15 28.6 NR 9.52 12.4 (mean)
Heijmen et al.16 63.4 9.76 4.88 15 (median)
Nelson et al.17 9.09 36.36 NR 10.3 (mean)
Galland et al.18 48 4.76 NR 17 (median)
Ho et al.19 28.6 14.29 28.57 20.8 (median)
Ho and Moll20 42.2 NR NR NR
Mean/median 32.2/28.6 14.4/11.9 7.1/5.9
NR, not reported.
316 G.A. Antoniou et al.It is therefore rational to argue that patients with heavy
calcification of the SFA should probably not be considered
for RSFAE. Failure to pass the guide wire across the distal
plaque end-point might have accounted for a higher per-
centage of the total technical failures if Devalia et al.10
and Galland et al.18 had not modified the original technique
by passing the guide wire into the popliteal artery, distal to
the occlusion, under local anaesthesic prior to the opera-
tive procedure.25 In the existing literature most proce-
dure-related complications were minor requiring no major
intervention or conversion to conventional open bypass
surgery.
The initial procedure described by Ho et al.2 included
positioning of a short balloon-expandable Palmaz stent
over the distal intimal edge to prevent any further dissec-
tion. A few years later the same authors19 proposed place-
ment of an endograft to cover the whole length of the
endarterectomised SFA combined with distal stent place-
ment. The technique was based on the observation26
that 46% of the limbs treated with RSFAE developedFigure 3 (a) Haemodynamically significant stenosis developed fo
where a stent had been deployed. (b) Correction of the lesion with
(VIABAHN).recurrent stenoses located within the endarterectomised
SFA segment after a mean interval of 5.8 months. Recently
three multi-centre studies used a new stent made of nickel
titanium, manufactured in a double spiral configuration
and covered with ePTFE, which has the advantages of
high radial strength, flexibility and resistance to compres-
sion and torsional stresses proximal to the knee joint.7,11,12
No evidence exists to justify the superiority of this stent
over the other stents used. Additionally, no randomized
trials have been found comparing the efficacy of stent or
endograft placement.
All studies assessed demonstrated considerable immedi-
ate clinical improvement after RSFAE represented by the
mean ABPI increase. The weighted mean cumulative pri-
mary and assisted primary patency rates were 57 and 77% at
2 years, respectively. Five year results after RSFAE were
reported by two studies only.10,14 One study14 in which 183
limbs were treated, reported a secondary patency rate of
49% at 5 years. From the existing literature, it appears
that the outcomes of RSFAE are not significantly inferiorur months later at the distal end of the endarterectomized SFA,
cutting balloon angioplasty and placement of a covered stent
Remote Superficial Femoral Artery Endarterectomy 317to those of subintimal angioplasty or femoropopliteal by-
pass.27,28 However, to draw definite conclusions at least
one randomized study comparing the outcome of RSFAE
with that of subintimal angioplasty and femoro-popliteal
bypass is required.
The large number of interventions required to maintain
assisted and secondary patency following RSFAE suggests
that patients should undergo an intensive clinical and
duplex surveillance program postoperatively to detect
restenosis and/or reocclusion, which probably needs to be
continued indefinitely.29,30 Ho et al.29 found that early (<1
year) detection and treatment of recurrent stenoses signifi-
cantly improved the mid-term patency rates. Galland
et al.30 found that, excluding the cost of duplex surveil-
lance, the cost of maintaining RSFAE patency was approxi-
mately five times that of maintaining in situ bypass
patency. It was concluded that the initial cost advantage
of shortened hospital stay is probably offset by the in-
creased cost of maintaining patency. Of interest is the
observation by various authors that reocclusion of the SFA
due to failed RSFAE was not associated with worsening of
symptoms compared with the preoperative state, which
might be explained by the reopening and preservation of
SFA collaterals. Smeets et al.31 found that 80% of patients
who had undergone RSFAE had improved or unchanged
symptoms following re-occlusion, reporting an amputation
rate of 0.8%.
In conclusion, long segment SFA disease has been tradi-
tionally difficult to treat with endovascular techniques.
RSFAE is a relatively newminimally invasive techniquewhose
role in the treatment of peripheral arterial disease remains
to be defined. Our review has shown that RSFAE carries
acceptable technical success rates and complication rates,
and short-, medium- and long-term results. RSFAE does
require a large number of secondary interventions to
maintain patency. Patients should undergo at least 1-year
postoperative clinical and duplex scanning surveillance. At
present it is unclear whether this treatment compares
favorably with conventional bypass surgery or with other
treatment modalities for long segment SFA disease, such as
subintimal angioplasty, as there are no randomized con-
trolled trials comparing RSFAE with other treatments. Thus
further research is needed to assess the usefulness of RSFAE.References
1 Klinkert P, Schepers A, Burger DH, van Bockel JH, Breslau PJ.
Vein versus polytetrafluoroethylene in above-knee femoropopli-
teal bypass grafting: five-year results of a randomized con-
trolled trial. J Vasc Surg 2003;37:149e55.
2 Dormandy JA, Rutherford RB. Management of peripheral arte-
rial disease (PAD). TASC working group. TransAtlantic Inter-
Society Concensus (TASC). J Vasc Surg 2000;31(1 Pt 2):S1e296.
3 Dos Santos JC. Sur la desobstruction des thromboses arterielles
anciennes. Mem Acad Chir 1947;73:409e11.
4 Ho GH, Moll FL, Joosten PP, van de Pavoordt ED, Overtoom TT.
The Mollring Cutter remote endarterectomy: preliminary
experience with a new endovascular technique for treatment
of occlusive superficial femoral artery disease. J Endovasc
Surg 1995;2(3):278e87.
5 Teijink JA, van den Berg JC, Moll FL. A minimally invasive tech-
nique in occlusive disease of the superficial femoral artery:remote endarterectomy using the MollRing Cutter. Ann Vasc
Surg 2001;15(5):594e8.
6 Ali AT, Kalapatapu V, Ahmed O, Moursi M, Eidt JF. Remote super-
ficial femoral artery endarterectomy: early results for TASC D
lesions in patients with severe ischemia. Vasc Endovascular
Surg 2007;41(4):310e5.
7 Rosenthal D, Martin JD, Smeets L, Devries JP, Gisbertz S,
Wellons ED, et al. Remote superficial femoral artery endarter-
ectomy and distal aSpire stenting: results of a multinational
study at three-year follow-up. J Cardiovasc Surg 2006;47(4):
385e91.
8 Heerinckx C, Verbist J, Haenen L, Deferm H, Deloose K,
Bosiers M, et al. Balloon-expandable, radially reinforced ePTFE
relining of the superficial femoral artery after remote endarter-
ectomy. J Cardiovasc Surg 2006;47(3):279e84.
9 Martin JD, Hupp JA, Peeler MO, Warble PB. Remote endarterec-
tomy: lessons learned after more than 100 cases. J Vasc Surg
2006;43(2):320e6.
10 Devalia K, Magee TR, Galland RB. Remote superficial femoral
endarterectomy: long-term results. Eur J Vasc Endovasc Surg
2006;31(3):262e5.
11 Knight JS, Smeets L, Morris GE, Moll FL. Multi centre study to
assess the feasibility of a new covered stent and delivery
system in combination with remote superficial femoral artery
endarterectomy (RSFAE). Eur J Vasc Endovasc Surg 2005;
29(3):287e94.
12 Rosenthal D, Martin JD, Schubart PJ, Wellons ED, Shuler FW,
Levitt AB. Remote superficial femoral artery endarterectomy
and distal aSpire stenting: multicenter medium-term results.
J Vasc Surg 2004;40(1):67e72.
13 Rosenthal D, Martin JD, Schubart PJ, Wellons ED. Remote super-
ficial femoral artery endarterectomy. J Cardiovasc Surg 2004;
45(3):185e92.
14 Smeets L, Ho GH, Hagenaars T, van den Berg JC, Teijink JA,
Moll FL. Remote endarterectomy: first choice in surgical treat-
ment of long segmental SFA occlusive disease? Eur J Vasc Endo-
vasc Surg 2003;25(6):583e9.
15 Rosenthal D, Wellons ED, Matsuura JH, Ghegan M, Shuler FW,
Laszlo Pallos L. Remote superficial femoral artery endarterec-
tomy and distal vein bypass for limb salvage: initial experience.
J Endovasc Ther 2003;10(1):121e5.
16 Heijmen RH, Teijink JA, van den Berg JC, Overtoom TT,
Pasterkamp G, Moll FL. Use of a balloon-expandable, radially
reinforced ePTFE endograft after remote SFA endarterectomy:
a single-center experience. J Endovasc Ther 2001;8(4):
408e16.
17 Nelson PR, Powell RJ, Proia RR, Schermerhorn ML, Fillinger MF,
Zwolak RM, et al. Results of endovascular superficial femoral
endarterectomy. J Vasc Surg 2001;34(3):526e31.
18 Galland RB, Whiteley MS, Gibson M, Simmons MJ, Torrie EP,
Magee TR. Remote superficial femoral artery endarterectomy:
medium-term results. Eur J Vasc Endovasc Surg 2000;19(3):
278e82.
19 Ho GH, Moll FL, Tutein Nolthenius RP, van den Berg JC,
Overtoom TT. Endovascular femoropopliteal bypass combined
with remote endarterectomy in SFA occlusive disease: initial
experience. Eur J Vasc Endovasc Surg 2000;19(1):27e34.
20 Ho GH, Moll FL. Remote endarterectomy in SFA occlusive
disease. Eur J Radiol 1998;28(3):205e10.
21 Ho GH, Moll FL, Hedeman Joosten PP, van de Pavoordt HD, van
den Berg JC, Overtoom TT. Endovascular remote endarterec-
tomy in femoropopliteal occlusive disease: one-year clinical
experience with the ring strip cutter device. Eur J Vasc
Endovasc Surg 1996;12(1):105e12.
22 Rosenthal D, Schubart PJ, Kinney EV, Martin JD, Sharma R,
Matsuura JH, et al. Remote superficial femoral artery endarter-
ectomy: multicenter medium-term results. J Vasc Surg 2001;
34(3):428e32.
318 G.A. Antoniou et al.23 Moll FL, Ho GH. Closed superficial femoral artery endarterec-
tomy: a 2-year follow-up. Cardiovasc Surg 1997;5(4):398e400.
24 Moll FL, Ho GH, Joosten PP, van de Pavoordt HD, Overtoom TT.
Endovascular remote endarterectomy in femoropopliteal long
segmental occlusive disease. A new surgical technique illus-
trated and preliminary results using a ring strip cutter device.
J Cardiovasc Surg 1996;37(3 Suppl. 1):39e40.
25 Whiteley MS, Magee TR, Torrie EP, Galland RB. Minimally inva-
sive superficial femoral artery endarterectomy: early experi-
ence with a modified technique. Eur J Vasc Endovasc Surg
1998;16(3):254e8.
26 Ho GH, van Buren PA, Moll FL, van der Bom JG, Eikelboom BC.
Incidence, time-of-onset, and anatomical distribution of recur-
rent stenoses after remote endarterectomy in superficial femo-
ral artery occlusive disease. J Vasc Surg 1999;30(1):106e13.27 Dorrucci V. Treatment of superficial femoral artery occlusive
disease. J Cardiovasc Surg 2004;45:193e201.
28 Markose G, Bolia A. Subintimal angioplasty in the management
of lower limb ischaemia. J Cardiovasc Surg 2006;47:399e406.
29 Ho GH, Van Buren PA, Moll FL, van der Bom JG, Eikelboom BC.
The importance of revision of early restenosis after endovascu-
lar remote endarterectomy in SFA occlusive disease. Eur J Vasc
Endovasc Surg 2000;19(1):35e42.
30 Galland RB, Whiteley MS, Gibson M, Simmons MJ, Torrie EP,
Magee TR. Maintenance of patency following remote superficial
femoral artery endarterectomy. Cardiovasc Surg 2000;8(7):533e7.
31 Smeets L, Huijbregts HJ, Ho GH, De Vries JP, Moll FL. Clinical
outcome after re-occlusion of initially successful remote endar-
terectomy of the superficial femoral artery. J Cardiovasc Surg
2007;48(3):309e14.
